XP
Xenon Pharmaceuticals Inc
🇺🇸XNAS.XENEUnited StatesHealthcare
$56.95USDdown -1.24 (-2.13%)ClosedEnd of day9:47 PM
Price$56.95-1.24 (-2.13%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA98420N1050
- CUSIP
- 98420N105
Company
- Employees
- 358
- Headquarters
- Burnaby, United States
- Website
- https://www.xenon-pharma.com
- CEO
- Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Market
- Shares outstanding
- 96.8M
- Market cap
- $5.52B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $5.52B
- EPS LTM
- -$4.11
- P/E LTM
- -14.69
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$409.2M-47.07%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$338.53M-46.23%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.